Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Oncology|May 12, 2020
Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 PatientsPrashant R Tembhare, Gaurav Narula, Twinkle Khanka, et al.Journal for Immunotherapy of Cancer|May 23, 2020
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapyPrashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, et al.Cytometry. Part B, Clinical Cytometry|June 15, 2019
A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 PatientsPrashant R Tembhare, Papagudi G Subramanian Pg, Sitaram Ghogale, et al.Cytometry. Part B, Clinical Cytometry|February 25, 2022
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometryAnumeha Chaturvedi, Dhanalaxmi Shetty, Sitaram Gundu Ghogale, et al.Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.Pageof 2